Although molecular signatures, including coding genes, have been developed in order to refine the different PTCL subtypes [86], others are not clearly distinguishable, such as between PTCL-NOS and ALK− ALCL. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.